Circulating tumor markers: a guide to their appropriate clinical use | Comparative summary of recommendations from clinical practice guidelines (PART 2)
Int J Biol Markers
.
2017 Mar 2;32(1):e1-e52.
doi: 10.5301/ijbm.5000259.
Authors
Massimo Gion
1
,
Chiara Trevisiol
2
,
Anne W S Rutjes
3
,
Giulia Rainato
2
,
Aline S C Fabricio
1
Affiliations
1
Regional Center and Program for Biomarkers, Department of Clinical Pathology and Transfusion Medicine, Azienda ULSS 3 Serenissima, Venice - Italy.
2
Istituto Oncologico Veneto IOV - IRCCS, Padova - Italy.
3
Institute of Social and Preventive Medicine, University of Bern, Bern - Switzerland.
PMID:
28255982
DOI:
10.5301/ijbm.5000259
No abstract available
Publication types
Comparative Study
MeSH terms
Biomarkers, Tumor / blood*
Humans
Neoplasms / blood
Neoplasms / diagnosis*
Practice Guidelines as Topic / standards*
Substances
Biomarkers, Tumor